| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |